Table 1

β Adrenoreceptor densities on peripheral blood mononuclear cells, magnetic resonance imaging findings, clinical status, and disability scores in five patients with primary progressive multiple sclerosis in a six month follow up study

Months of follow up
Patient detailsFirstSecondThirdFourthFifthSixth
Bold numbers indicate significantly increased values (above mean value of the controls plus 3 SD).
 E, enhanced MRI lesions; RM, remission.
Patient 1 (49 years; male)
β Adrenergic receptor sites/cell12001289 2489 149914901540
MRI, brain
MRI, spinal cord1 E
Clinical statusRMRMRMRMRMRM
Kurtzke score7.07.07.07.57.57.5
Patient 2 (32 years; male)
β Adrenergic receptor sites/cell10201100 2300 160012791550
MRI, brain
MRI, spinal cord1 E
Clinical statusRMRMRMRMRMRM
Kurtzke score3.03.04.04.04.05.0
Patient 3 (40 years; male)
β Adrenegic receptor sites/cell140013501200130015001400
MRI, brain
MRI, spinal cord
Clinical statusRMRMRMRMRMRM
Kurtzke score6.56.56.56.56.56.5
Patient 4 (46 years; male)
β Adrenergic receptor sites/cell120015001300128015001400
MRI, brain
MRI, spinal cord
Clinical statusRMRMRMRMRMRM
Kurtzke score7.07.07.07.57.57.5
Patient 5 (46 years; male)
β Adrenergic receptor sites/cell160015001400155016001500
MRI, brain
MRI, spinal cord
Clinical scoreRMRMRMRMRMRM
Kurtzke score5.05.05.05.06.06.0